Safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS)

Informacje na temat projektu

TUDCA-ALS

Identyfikator umowy o grant: 755094

DOI 10.3030/755094

Projekt został zamknięty

Data podpisania przez KE 15 Listopada 2017

Data rozpoczęcia 1 Stycznia 2018

Data zakończenia 31 Grudnia 2023

Finansowanie w ramach

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Koszt całkowity € 5 596 928,00

Wkład UE € 5 596 928,00

Koordynowany przez

HUMANITAS MIRASOLE SPA
Italy

Rezultaty

Documents, reports (1)

Dissemination and exploitation plan

Dissemination and Exploitation Plan. The document will describe the dissemination and exploitation strategies and action plan (Month 3

Websites, patent fillings, videos etc. (1)

Project website

Project website. The report will include the characteristics of the website, the activities involved for its creation and print screens of the website pages (Month 6

Publikacje

Peer reviewed articles (6)

Review of disease-modifying drug trials in amyotrophic lateral sclerosis

Autorzy: Paolo Tornese; Stefania Lalli; Antoniangela Cocco; Alberto Albanese
Opublikowane w: Journal of Neurology Neurosurgery and Psychiatry, Numer 3, 2022, Strona(/y) 521-529, ISSN 0022-3050
Wydawca: BMJ Publishing Group
DOI: 10.1136/jnnp-2021-328470

Tauro-Urso-Deoxycholic Acid Trials in Amyotrophic Lateral Sclerosis: What is Achieved and What to Expect

Autorzy: Maria Lo Giudice, Antoniangela Cocco, Giorgio Reggiardo, Stefania Lalli, Alberto Albanese
Opublikowane w: Clinical Drug Investigation, 2023, ISSN 1179-1918
Wydawca: Springer
DOI: 10.1007/s40261-023-01324-0

Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases

Autorzy: Kareem Khalaf; Paolo Tornese; Antoniangela Cocco; Alberto Albanese
Opublikowane w: Translational Neurodegeneration, Numer 3, 2022, Strona(/y) 33, ISSN 2047-9158
Wydawca: Springer Nature
DOI: 10.1186/s40035-022-00307-z

A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial

Autorzy: Flavia L Lombardo, Stefania Spila Alegiani, Flavia Mayer, Marta Cipriani, Maria Lo Giudice, Albert Christian Ludolph, Christopher J McDermott, Philippe Corcia, Philip Van Damme, Leonard H Van den Berg, Orla Hardiman, Gabriele Nicolini, Nicola Vanacore, Brian Dickie, Alberto Albanese, Maria Puopolo; TUDCA-ALS Study Group (Paolo Tornese, Antoniangela Cocco, Michela Matteoli, Eliana Lauranzano, Maria
Opublikowane w: Trials, 2023, ISSN 1745-6215
Wydawca: BioMed Central
DOI: 10.1186/s13063-023-07638-w

Cox regression and survival analysis from the tauro-urso-deoxycholic trial in amyotrophic lateral sclerosis

Autorzy: Giorgio Reggiardo; Maria Lo Giudice; Stefania Lalli; Gilberto Rinaldi; Alberto Albanese
Opublikowane w: Frontiers in Neurology, Numer 5, 2023, ISSN 1664-2295
Wydawca: Frontiers Research Foundation
DOI: 10.3389/fneur.2023.1163855

Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol

Autorzy: Alberto Albanese, Albert Christian Ludolph, Christopher J McDermott, Philippe Corcia, Philip Van Damme, Leonard H Van den Berg, Orla Hardiman, Gilberto Rinaldi, Nicola Vanacore, Brian Dickie, TUDCA-ALS Study Group (Tornese Paolo, Cocco Antoniangela, Lo Giudice Maria, Matteoli Michela, Lauranzano Eliana, Malosio Maria Luisa, Adriana Elia Chiara, Lombardo Flavia, Mayer Flavia, Puopolo Maria, Alegian
Opublikowane w: Frontiers in Neurology, Numer 16642295, 2022, ISSN 1664-2295
Wydawca: Frontiers Research Foundation
DOI: 10.3389/fneur.2022.1009113